Your browser doesn't support javascript.
loading
Mostrar: 20 | 50 | 100
Resultados 1 - 2 de 2
Filtrar
Más filtros











Base de datos
Intervalo de año de publicación
1.
Development ; 140(16): 3311-22, 2013 Aug.
Artículo en Inglés | MEDLINE | ID: mdl-23863483

RESUMEN

Pluripotent mouse embryonic stem cells (mESCs), maintained in the presence of the leukemia inhibitory factor (LIF) cytokine, provide a powerful model with which to study pluripotency and differentiation programs. Extensive microarray studies on cultured cells have led to the identification of three LIF signatures. Here we focus on muscle ras oncogene homolog (MRAS), which is a small GTPase of the Ras family encoded within the Pluri gene cluster. To characterise the effects of Mras on cell pluripotency and differentiation, we used gain- and loss-of-function strategies in mESCs and in the Xenopus laevis embryo, in which Mras gene structure and protein sequence are conserved. We show that persistent knockdown of Mras in mESCs reduces expression of specific master genes and that MRAS plays a crucial role in the downregulation of OCT4 and NANOG protein levels upon differentiation. In Xenopus, we demonstrate the potential of Mras to modulate cell fate at early steps of development and during neurogenesis. Overexpression of Mras allows gastrula cells to retain responsiveness to fibroblast growth factor (FGF) and activin. Collectively, these results highlight novel conserved and pleiotropic effects of MRAS in stem cells and early steps of development.


Asunto(s)
Células Madre Embrionarias/enzimología , Regulación del Desarrollo de la Expresión Génica , Proteínas de Unión al GTP Monoméricas/metabolismo , Xenopus laevis/embriología , Activinas/farmacología , Secuencia de Aminoácidos , Animales , Biomarcadores/metabolismo , Encéfalo/embriología , Encéfalo/enzimología , Secuencia Conservada , Inducción Embrionaria , Células Madre Embrionarias/efectos de los fármacos , Células Madre Embrionarias/metabolismo , Femenino , Factores de Crecimiento de Fibroblastos/farmacología , Gástrula/citología , Gástrula/efectos de los fármacos , Gástrula/enzimología , Técnicas de Silenciamiento del Gen , Proteínas de Homeodominio/genética , Proteínas de Homeodominio/metabolismo , Factor Inhibidor de Leucemia/farmacología , Ratones , Datos de Secuencia Molecular , Proteínas de Unión al GTP Monoméricas/genética , Proteína Homeótica Nanog , Neurogénesis , Factor 3 de Transcripción de Unión a Octámeros/genética , Factor 3 de Transcripción de Unión a Octámeros/metabolismo , Ovario/enzimología , Xenopus laevis/genética , Xenopus laevis/metabolismo , Proteínas ras
2.
Stem Cell Rev Rep ; 8(1): 1-15, 2012 Mar.
Artículo en Inglés | MEDLINE | ID: mdl-21537995

RESUMEN

LIF, a member of the IL6 family of cytokine, displays pleiotropic effects on various cell types and organs. Its critical role in stem cell models (e.g.: murine ES, human mesenchymal cells) and its essential non redundant function during the implantation process of embryos, in eutherian mammals, put this cytokine at the core of many studies aiming to understand its mechanisms of action, which could benefit to medical applications. In addition, its conservation upon evolution raised the challenging question concerning the function of LIF in species in which there is no implantation. We present the recent knowledge about the established and potential functions of LIF in different stem cell models, (embryonic, hematopoietic, mesenchymal, muscle, neural stem cells and iPSC). We will also discuss EVO-DEVO aspects of this multifaceted cytokine.


Asunto(s)
Factor Inhibidor de Leucemia/fisiología , Transducción de Señal , Células Madre/fisiología , Animales , Expresión Génica , Regulación de la Expresión Génica , Pleiotropía Genética , Humanos , Factor Inhibidor de Leucemia/genética , Factor Inhibidor de Leucemia/metabolismo , Células Madre/metabolismo , Factores de Transcripción/metabolismo , Proteína p53 Supresora de Tumor/metabolismo
SELECCIÓN DE REFERENCIAS
DETALLE DE LA BÚSQUEDA